Human gene therapy - JoVE Visualize

Showing results (1281-1290 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|March 21, 2000

The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibersR Pruchnic, B Cao, Z Q Peterson, et al.

Human Gene Therapy|March 21, 2000

Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivoY He, A A Pimenov, J V Nayak, et al.

Human Gene Therapy|March 21, 2000

Partial correction of the urinary concentrating defect in aquaporin-1 null mice by adenovirus-mediated gene deliveryB Yang, T Ma, J Y Dong, et al.

Human Gene Therapy|April 11, 2000

Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccineC L Hsieh, D S Chen, L H Hwang

Human Gene Therapy|April 11, 2000

An enhanced system for construction of adenoviral vectors by the two-plasmid rescue methodP Ng, R J Parks, D T Cummings, et al.

Human Gene Therapy|April 11, 2000

Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular routeW K Cho, S Ebihara, J Nalbantoglu, et al.

Human Gene Therapy|April 11, 2000

Correction of acid beta-galactosidase deficiency in GM1 gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: higher efficiency of release and cross-correction by the murine enzymeM Sena-Esteves, S M Camp, J Alroy, et al.

Human Gene Therapy|April 11, 2000

Adenovirus vector-mediated gene transfer to regional lymph nodesD Labow, S Lee, R J Ginsberg, et al.

Human Gene Therapy|September 25, 1999

In vitro analysis of transformation potential associated with retroviral vector insertionsS K Powell, M Kaloss, I Burimski, et al.

Human Gene Therapy|September 25, 1999

Persistent, therapeutically relevant levels of human granulocyte colony-stimulating factor in mice after systemic delivery of adeno-associated virus vectorsD D Koeberl, L Bonham, C L Halbert, et al.

Pageof 413

Showing results (1281-1290 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|March 21, 2000

The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibersR Pruchnic, B Cao, Z Q Peterson, et al.

Human Gene Therapy|March 21, 2000

Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivoY He, A A Pimenov, J V Nayak, et al.

Human Gene Therapy|March 21, 2000

Partial correction of the urinary concentrating defect in aquaporin-1 null mice by adenovirus-mediated gene deliveryB Yang, T Ma, J Y Dong, et al.

Human Gene Therapy|April 11, 2000

Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccineC L Hsieh, D S Chen, L H Hwang

Human Gene Therapy|April 11, 2000

An enhanced system for construction of adenoviral vectors by the two-plasmid rescue methodP Ng, R J Parks, D T Cummings, et al.

Human Gene Therapy|April 11, 2000

Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular routeW K Cho, S Ebihara, J Nalbantoglu, et al.

Human Gene Therapy|April 11, 2000

Correction of acid beta-galactosidase deficiency in GM1 gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: higher efficiency of release and cross-correction by the murine enzymeM Sena-Esteves, S M Camp, J Alroy, et al.

Human Gene Therapy|April 11, 2000

Adenovirus vector-mediated gene transfer to regional lymph nodesD Labow, S Lee, R J Ginsberg, et al.

Human Gene Therapy|September 25, 1999

In vitro analysis of transformation potential associated with retroviral vector insertionsS K Powell, M Kaloss, I Burimski, et al.

Human Gene Therapy|September 25, 1999

Persistent, therapeutically relevant levels of human granulocyte colony-stimulating factor in mice after systemic delivery of adeno-associated virus vectorsD D Koeberl, L Bonham, C L Halbert, et al.

Pageof 413